This Stock Has a Zero-Dollar Price Target

The S&P and Nasdaq are up modestly at midday

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

MIDDAY MARKET CHECK     6/27/2019
The #1 Biotech Stock to Own Today On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
Dow Down After Kudlow Tariff Comments By Karee Venema Share On It's a choppy trading session on Wall Street today, as Wall Street gets blitzed with trade buzz before this weekend's meeting between U.S. President Donald Trump and Chinese leader Xi Jinping at the G-20 summit. Most recently, top White House economic advisor Larry Kudlow said no preconditions have been arranged for the meeting, and the U.S. could implement new tariffs on Chinese goods. At last check, the Dow Jones Industrial Average (DJI) was last seen slightly lower on Boeing (BA) headwinds, while the S&P 500 Index (SPX) and Nasdaq Composite (IXIC) are up modestly -- with the SPX on track to snap its four-day losing streak. Continue reading for more on today's market, including:  Why Evercore ISI has a zero-dollar price target on this stock. Options traders are in overdrive as Conagra eyes worst day of 2019. Plus, a bullish options bet on small caps; the real estate stock breaking out; and Pier 1 sinks to the bottom of the Big Board. >> Continue reading...
LATEST HEADLINES
>> Worst Stocks for July and Beyond These stocks tend to wilt in the summer months >> Nonfarm Payrolls Release Highlights Holiday Week U.S.-China trade drama will likely be a focal point too >> INTC Shares Hit By Bear Note During Test of Key Trendlines Intel is the middle of a rough patch on the charts >> Conagra Stock Crumbles After Earnings Miss CAG puts are flying off the shelves this morning >> Rite Aid Stock Pops on New FAANG Partnership This is overshadowing a dreary earnings report and round of bear notes ADVERTISEMENT Turn $1,000 into $1.57 Million - with "Holy Grail of Medicine" On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
To ensure delivery of Schaeffer's Midday Market Check, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Midday Market Check or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Midday Market Check? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S MIDDAY MARKET CHECK enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com